BOSTON--(BUSINESS WIRE)--Ancora Heart, Inc., a company developing a completely transcatheter device-based therapy to address heart failure (HF), today announced that patients treated with the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback